The Mechanism of Bisdemethoxycurcumin Enhances Conventional Antibiotics against Methicillin-Resistant Staphylococcus aureus

Methicillin-resistant (MRSA) infection has posed a serious threat to public health, therefore, the development of new antibacterial drugs is imperative. Bisdemethoxycurcumin (BDMC) is a curcumin analog that exists in nature and possesses extensive pharmacological actions. This review focuses on inve...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of molecular sciences 2020-10, Vol.21 (21), p.7945
Hauptverfasser:	Wang, Shu, Kim, Min-Chul, Kang, Ok-Hwa, Kwon, Dong-Yeul
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenosine triphosphatase Ampicillin - pharmacology Anti-Bacterial Agents - pharmacology Antibacterial activity Antibiotics Antimicrobial agents Assaying Bacterial infections Bacterial Proteins - genetics Bacterial Proteins - metabolism Curcumin Diarylheptanoids - pharmacology Dilution Down-Regulation Drug development Drug resistance Drug Synergism Gene Expression Regulation, Bacterial - drug effects MecA protein Methicillin Methicillin-Resistant Staphylococcus aureus - drug effects Methicillin-Resistant Staphylococcus aureus - genetics Methicillin-Resistant Staphylococcus aureus - metabolism Microbial Sensitivity Tests Nosocomial infections Oxacillin - pharmacology Penicillin Penicillin-binding protein Penicillin-binding protein 2a Penicillin-Binding Proteins - genetics Penicillin-Binding Proteins - metabolism Permeability Polymerase chain reaction Protein expression Proteins Public health Reagents Signal transduction Staphylococcus aureus Staphylococcus infections Synergistic effect Transcription
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!